Johnson & Johnson (JNJ)Sen. John Boozman disclosed a partial sale $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

22 days

Disclosure lag

Traded

Aug 20, 2026

Disclosed

Sep 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
2. Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
3. Jun 9, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
4. Jun 25, 2026FDAFDA device clearance: Coated VICRYL™ (Polyglactin 910) Plus Antibacterial Suture
5. Jun 25, 2026FDAFDA device clearance: ATTUNE Total Knee System; ATTUNE Cementless Knee System
6. Jun 25, 2026FDAFDA device clearance: VELYS™ Robotic-Assisted Solution
7. Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
8. Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
9. Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
10. Jul 23, 2026FDARecall: Velys Enabling Tech Robotic-Assist Station REF: 451611001
11. Jul 25, 2026FDAFDA device clearance: MONARCH™ Platform (MON-000008)
12. Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
13. Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
14. Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
15. Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
16. Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
17. Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
18. Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
19. Aug 6, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
20. Aug 12, 2026FDARecall: Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella Controller, Packaged, CA; Product Code: 0042…
21. Aug 12, 2026FDARecall: Impella Optical Controller with the below product descriptions and corresponding Product Codes. 1. Impella Optical Controller, Packaged, AU; Product Code: 0042…
22. Aug 12, 2026FDARecall: Impella Optical Controller, Automated Impella Controller, Impella Connect Package with the below product descriptions and corresponding Product Codes. 1. Optic…
23. Aug 13, 2026Insider · 1 personInsiders: 2 sales (~$32.2M)
24. Aug 17, 2026Insider · Named in an 8-K 13 days earlierOfficer sold ~$3.95M of JNJ shares in the open market
25. Aug 20, 2026 · this disclosureCongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000

What came next

1. Aug 24, 2026FDAFDA drug approval: Imaavy
2. Aug 27, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
3. Aug 28, 2026FDAFDA drug approval: Stelara
4. Sep 2, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
5. Sep 2, 2026Insider · 1 personInsiders: 2 sales (~$9.2M)
6. Sep 4, 2026FDAFDA device clearance: ATTUNE Revision Knee System
7. Sep 8, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
8. Sep 17, 2026FDAFDA device clearance: HARMONIC 1100 Shears (HAR1120); HARMONIC 1100 Shears (HAR1136)
9. Oct 5, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Sen. John Boozman

• Senate eFD periodic transaction report at Constellation Energy (CEG)Sep 11, 2026
• Senate eFD periodic transaction report at Otis Worldwide (OTIS)Sep 11, 2026
• Senate eFD periodic transaction report at First Solar (FSLR)Sep 11, 2026
• Senate eFD periodic transaction report at Cboe Global Markets (CBOE)Aug 20, 2026
• Senate eFD periodic transaction report at Cboe Global Markets (CBOE)Aug 17, 2026

The full history of Sen. John Boozman is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026
• SEC Form 4Sep 4, 2026

Everything OQRO holds on this company is on its JNJ page.